$3,798,130
+1.1%
Board Vice Chair
2024
$3.5M related
--
$303k other
--
Board Vice Chair at Rush to Crush Cancer
Fiscal year ended June 30, 2024. Published on January 25, 2026.
Total compensation
Stanley Marks, M.D. has been listed as an employee of Rush to Crush Cancer in Form 990 filings since fiscal year 2022. Total compensation for Stanley Marks, M.D. has increased by 11.8% from 2022 to 2024.